A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group study (Q33494642)
scientific article
Language:
(P31) (Q13442814)
(P304) 254-255
(P433) 3
(P478) 4
(P577) Monday, March 1, 1993
(P921) (Q42824440)
(Q18975855)
(Q16)
(P1433) (Q326122)
(P1476) "A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group study" (language: en)
(P2093) S Verma
I C Quirt
E A Eisenhauer
N A Iscoe
V J Young
A J Bodurtha
J Davidson
other details
description scientific article

External Links